Header Logo

Connection

Mignonette Du Plessis to Influenza Vaccines

This is a "connection" page, showing publications Mignonette Du Plessis has written about Influenza Vaccines.
Connection Strength

0,571
  1. A Potential Platform for Future Vaccine Trials Identifies a High Incidence of Symptomatic and Asymptomatic Influenza Infection Among Children Aged 6 to 23 Months in South Africa. J Infect Dis. 2025 Feb 20; 231(2):e328-e336.
    View in: PubMed
    Score: 0,207
  2. Home-Based Testing as an Approach to Estimate Influenza Vaccine Effectiveness in South Africa, 2021-2022-A Pilot Study. Influenza Other Respir Viruses. 2024 12; 18(12):e70034.
    View in: PubMed
    Score: 0,204
  3. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Euro Surveill. 2021 07; 26(29).
    View in: PubMed
    Score: 0,161
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.